Registration of Acute Ischemic Stroke With Large and Medium-sized Vascular Occlusion in Southwest China(LMVOS)
NCT ID: NCT06125236
Last Updated: 2023-11-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
8000 participants
OBSERVATIONAL
2023-11-09
2046-05-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Registry of Acute Ischemic Stroke With Large- or Medium-vessel Occlusion
NCT05779215
Evaluation of Endovascular Treatment in Acute Intracranial Distal Medium Vessel Occlusion Stroke
NCT06146790
Cerebral Large Vessel Occlusion Stroke Multiomics Biosample Cohort
NCT06963489
Endovascular Treatment for Mild Stroke With Acute Anterior Circulation Large Vessel Occlusion
NCT06179017
Rescue Endovascular Therapy for Progressive Acute Mild Ischemic Stroke With Large Vascular Occlusion
NCT06155032
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Acute ischemic stroke with large- or medium-vessel occlusion
Acute ischemic stroke patients with large- or medium-vessel occlusion including all treatments.
Visit at D90
Visits at 90±7 days after stroke onset were conducted by trained and blinded investigators, with face-to-face, telephone call or Internet access.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Visit at D90
Visits at 90±7 days after stroke onset were conducted by trained and blinded investigators, with face-to-face, telephone call or Internet access.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Informed consent from the patient or surrogate.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zhengzhou Yuan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zhengzhou Yuan
Deputy Director of Stroke Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Zhengzhou Yuan, MD
Role: STUDY_CHAIR
Department of Neurology, Affiliated Hospital of Southwest Medical University, LuZhou, China.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Affiliated Hospital of Southwest Medical University
Luzhou, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Zhengzhou Yuan
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SWMU202309
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.